Immediate Impact
62 standout
Citing Papers
Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies
2024 Standout
Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future
2023 Standout
Works of Jang‐Ho Cha being referenced
Mavoglurant Augmentation in OCD Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Proof-of-Concept, Randomized, Placebo-Controlled, Phase 2 Study
2017
O1‐10‐06: Results From a First‐in‐Human Study with the Bace Inhibitor CNP520
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Jang‐Ho Cha | 118 | 12 | 40 | 100 | 45 | 10 | 202 | |
| Seth C. Baker | 57 | 12 | 70 | 66 | 53 | 9 | 258 | |
| Luisa Mari | 58 | 7 | 28 | 67 | 16 | 10 | 219 | |
| Kati Alakurtti | 102 | 44 | 107 | 36 | 31 | 8 | 253 | |
| Yuxian Ma | 123 | 2 | 71 | 81 | 26 | 8 | 196 | |
| Kerisa Shelton | 71 | 19 | 37 | 104 | 18 | 10 | 251 | |
| George Uhl | 55 | 20 | 104 | 76 | 47 | 9 | 292 | |
| Daniel van Kammen | 134 | 36 | 28 | 44 | 14 | 9 | 263 | |
| Mohammad Khoshnoodi | 90 | 4 | 70 | 79 | 19 | 14 | 278 | |
| Eastlyn Lewis | 31 | 22 | 45 | 53 | 38 | 12 | 152 | |
| Andrey Dovzhenok | 90 | 4 | 89 | 58 | 41 | 10 | 282 |
All Works
Login with ORCID to disown or claim papers
Loading papers...